Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Teiichi Tamura.
BMC Nephrology | 2013
Soichiro Iimori; Yumi Noda; Tomokazu Okado; Shotaro Naito; Takayuki Toda; Yoshiko Chida; Michio Kuwahara; Ryoichi Ando; Yasuhide Nishio; Yoshitaka Maeda; Hiroyuki Tanaka; Teiichi Tamura; Shigeaki Kimoto; Eiichiro Kanda; Seiji Inoshita; Momono Yoshikawa; Rie Okutsu; Masato Tajima; Takashi Kusaura; Katsuki Kobayashi; Tatemitsu Rai; Shinichi Uchida; Sei Sasaki
BackgroundAbout 39,000 patients were newly prescribed renal replacement therapy in Japan in 2011, resulting in a total of more than 300,000 patients being treated with dialysis. This high prevalence of treated end stage kidney disease (ESKD) patients is an emergent problem that requires immediate attention. We launched a prospective cohort study to evaluate population specific characteristics of the progression of chronic kidney disease (CKD). In this report, we describe the baseline characteristics and risk factors for cardiovascular disease (CVD) prevalence among this cohort.MethodsNew patients from 16 nephrology centers who were older than 20 years of age and who visited or were referred for the treatment of CKD stage 2–5, but were not on dialysis therapy, were recruited in this study. At enrollment, medical history, lifestyle behaviors, functional status and current medications were recorded, and blood and urine samples were collected. Estimated glomerular filtration rate (eGFR) was calculated by a modified three-variable equation.ResultsWe enrolled 1138 patients, 69.6% of whom were male, with a mean age of 68 years. Compared with Western cohorts, patients in this study had a lower body mass index (BMI) and higher proteinuria. The prevalence of CVD was 26.8%, which was lower than that in Western cohorts but higher than that in the general Japanese population. Multivariate analysis demonstrated the following association with CVD prevalence: hypertension (adjusted odds ratio (aOR) 3.57; 95% confidence interval (CI) 1.82-7.02); diabetes (aOR 2.45; 95% CI 1.86-3.23); hemoglobin level less than 11 g/dl (aOR 1.61; 95% CI 1.21-2.15); receiving anti-hypertensive agents (aOR 3.54; 95% CI 2.27-5.53); and statin therapy (aOR 2.73; 95% CI 2.04-3.66). The combination of decreased eGFR and increased proteinuria was also associated with a higher prevalence of CVD.ConclusionsThe participants in this cohort had a lower BMI, higher proteinuria and lower prevalence of CVD compared with Western cohorts. Lower eGFR and high proteinuria were associated with CVD prevalence. Prospective follow up of these study patients will contribute to establishment of individual population-based treatment of CKD.
Nephrology | 2014
Yohei Arai; Eiichiro Kanda; Hiroaki Kikuchi; Chisato Yamamura; Suguru Hirasawa; Shota Aki; Naoto Inaba; Makoto Aoyagi; Hiroyuki Tanaka; Teiichi Tamura; Sei Sasaki
Impaired mobility at the onset of dialysis is considered one of the most important risk factors for short‐term mortality after initiation of dialysis in elderly patients. However, whether a decline in mobility after starting dialysis also affects mortality is unclear.
Renal Failure | 2013
Shintaro Mandai; Makoto Aoyagi; Kiyotaka Nagahama; Yohei Arai; Suguru Hirasawa; Shota Aki; Naoto Inaba; Hiroyuki Tanaka; Yukio Tsuura; Teiichi Tamura; Sei Sasaki
Abstract A 37-year-old man developed Henoch--Schönlein purpura nephritis (HSPN) with nephrotic syndrome and rapidly progressive glomerulonephritis after otitis media and externa due to methicillin-resistant Staphylococcus aureus infection. Despite resolution of the infection and prednisolone therapy, his kidney disease worsened. However, the addition of cyclosporine A finally resulted in complete remission of the nephrotic syndrome. A review of similar cases with post-Staphylococcal infection HSPN revealed strong similarities between this entity and immunoglobulin A-dominant postinfectious glomerulonephritis (IgA-PIGN), an increasingly recognized form of PIGN typically associated with Staphylococcal infection, in both clinical and morphological features. Post-Staphylococcal infection HSPN may constitute a subgroup of IgA-PIGN.
CEN Case Reports | 2014
Hiroaki Kikuchi; Takanobu Yoshimoto; Hiroyuki Tanaka; Kazutaka Tsujimoto; Chisato Yamamura; Yohei Arai; Suguru Hirasawa; Shota Aki; Naoto Inaba; Makoto Aoyagi; Yoshihiro Ogawa; Teiichi Tamura
A 69-year-old woman presented with periodic hypertension, edema, and hypokalemia that occurred within an interval of a few weeks. Her laboratory test values showed autonomously elevated plasma adrenocorticotropic hormone (ACTH) and cortisol concentrations. The patient’s Cushingoid features were not evident on first admission. Several weeks later, in spite of constant oral potassium supplementation, severe hypokalemia recurred with Cushingoid features and worsening symptoms of leg edema and pigmentation, which spontaneously disappeared within a few days. Her periodic symptoms occurred in parallel with fluctuations of plasma ACTH and cortisol concentrations. A series of endocrinological and pituitary imaging findings led to a tentative diagnosis of cyclic Cushing’s syndrome caused by ectopic ACTH secretion. However, chest and abdominal computed tomography did not reveal any candidate lesion. The patient’s periodic hypercortisolemia and symptoms were well controlled after treatment with metyrapone plus dexamethasone. This is a very rare case of periodic hypokalemia and hypertension caused by cyclic Cushing’s syndrome.
Case Reports | 2013
Wakako Yoshioka; Takayasu Mori; Kiyotaka Nagahama; Teiichi Tamura
We report a 49-year-old man with alcoholic severe acute pancreatitis (SAP) complicated by drug-induced acute tubulointerstitial nephritis (DI-AIN). Oliguria persisted and became anuric again on day 17 despite improvement of pancreatitis. He presented rash, fever and eosinophilia from day 20. Renal biopsy was performed for dialysis-dependent acute kidney injury (AKI), DI-AIN was revealed, and prompt use of corticosteroids fully restored his renal function. This diagnosis might be missed because it is difficult to perform renal biopsy in such a clinical situation. If the patients general condition allows, renal biopsy should be performed and reversible AKI must be distinguished from many cases of irreversible AKI complicated by SAP. This is the first report of biopsy-proven DI-AIN associated with SAP, suggesting the importance of biopsy for distinguishing DI-AIN in persisting AKI of SAP.
Clinical and Experimental Nephrology | 2012
Daiei Takahashi; Kiyotaka Nagahama; Yukio Tsuura; Hiroyuki Tanaka; Teiichi Tamura
Clinical and Experimental Nephrology | 2017
Hiroaki Kikuchi; Eiichiro Kanda; Shintaro Mandai; Masanobu Akazawa; Soichiro Iimori; Katsuyuki Oi; Shotaro Naito; Yumi Noda; Takayuki Toda; Teiichi Tamura; Sei Sasaki; Eisei Sohara; Tomokazu Okado; Tatemitsu Rai; Shinichi Uchida
Internal Medicine | 2014
Hiroaki Kikuchi; Makoto Aoyagi; Kiyotaka Nagahama; Yu Yajima; Chisato Yamamura; Yohei Arai; Suguru Hirasawa; Shota Aki; Naoto Inaba; Hiroyuki Tanaka; Teiichi Tamura
Internal Medicine | 2014
Hiroaki Kikuchi; Makoto Aoyagi; Kiyotaka Nagahama; Chisato Yamamura; Yohei Arai; Suguru Hirasawa; Shota Aki; Naoto Inaba; Hiroyuki Tanaka; Teiichi Tamura
Clinical and Experimental Nephrology | 2013
Shintaro Mandai; Eiichiro Kanda; Yohei Arai; Suguru Hirasawa; Toshiyuki Hirai; Shota Aki; Naoto Inaba; Makoto Aoyagi; Hiroyuki Tanaka; Takaaki Ikeda; Teiichi Tamura; Sei Sasaki